The ASCVD risk score estimates your chance of a first heart attack or stroke over the next ten years. It comes from the Pooled Cohort Equations, the model that American heart and stroke guidelines use to decide who benefits most from statin therapy.
Your visual report appears here
Fill in the form and press Calculate. You will get your number, an interpretation chip, and a personalized chart pack drawn instantly in your browser.
- Risk spectrum with your position marked
- Reference ranges from the original publication
- Shareable link, nothing stored
Scientific references
Ten years of risk in one number
Atherosclerosis builds quietly for decades before it announces itself. The Pooled Cohort Equations were developed to make that invisible process visible. Researchers combined data from several long running American cohort studies, including Framingham and the ARIC study, and followed tens of thousands of adults to see who went on to have a heart attack or stroke. Age, sex, race, cholesterol levels, blood pressure, smoking, and diabetes emerged as the dominant predictors, and the published equations turn those inputs into a percentage.
How the equation reads your inputs
The model is not a simple checklist. Each input is transformed logarithmically and multiplied by a coefficient fitted to the cohort data, and several inputs interact with each other. Age interacts with cholesterol, for instance, because a given cholesterol level means something different at 40 than at 70. The result is a survival curve personalized to your profile, and one minus that survival probability is your ten year risk.
What the bands mean for treatment
Guidelines translate the percentage into action. Under 5 percent is low risk and usually calls for lifestyle measures alone. Between 5 and 7.5 percent sits a borderline zone where additional factors like family history or coronary calcium scores tip the decision. From 7.5 to 20 percent, moderate to high intensity statin therapy is generally recommended, and above 20 percent the case for aggressive treatment is strong. Blood pressure targets and aspirin decisions also reference this score.
Where the model strains
The equations were fitted on adults aged 40 to 79 without existing cardiovascular disease. Outside that window the estimate loosens. The model also tends to overestimate risk in some modern, well treated populations, because the original cohorts lived in an era with more smoking and less statin use. Newer calculators like PREVENT have started to address this, but the Pooled Cohort Equations remain the reference most guidelines still cite. Treat the output as a conversation starter with your clinician rather than a verdict, especially if your family history is unusual.